Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...
Philip Morris International Inc. (PM), headquartered in Stamford, Connecticut, is a leading global tobacco company dedicated ...
WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ... and other traditional tobacco products.
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and ...
IQOS's success in Egypt signals a promising opportunity for the introduction of additional smoke-free products to the market, ...
The Food and Drug Administration has authorized ZYN nicotine pouches, “making ZYN the first and only authorized nicotine pouch in the United ...
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...
PM's solid fundamentals and commitment to innovation and cost efficiencies position the company well for sustained growth ...
The U.S. Food and Drug Administration (FDA) today authorized ZYN nicotine pouches making ZYN the first and only authorized nicotine pouch in the United States. The FDA’s authorization of all ZYN ...
Philip Morris has stated it does not employ ... It competes with similar products from other tobacco competitors, including Altria’s On pouches.